Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
6.35
-0.32 (-4.80%)
At close: May 1, 2026, 4:00 PM EDT
6.20
-0.15 (-2.36%)
After-hours: May 1, 2026, 7:57 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $19.55 million as of May 1, 2026. Its market cap has decreased by -35.81% in one year.
Market Cap
19.55M
Enterprise Value
15.54M
1-Year Change
-35.81%
Ranking
Category
Stock Price
$6.35
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $19.55M, a decrease of -66.40%. That is a compound annual growth rate of -28.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 19.55M | 23.30% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 18.54M |
| Lipocine | 18.54M |
| Genenta Science | 16.97M |
| Pasithea Therapeutics | 16.81M |
| Theriva Biologics | 16.40M |
| SeaStar Medical Holding | 15.66M |
| NewcelX | 15.27M |
| IN8bio | 15.07M |